Literature DB >> 19415368

[Amyloidosis in liver biopsies].

Z Gioeva1, B Kieninger, C Röcken.   

Abstract

INTRODUCTION: We reassessed the histopathology and origin of amyloid in liver biopsies.
MATERIALS AND METHODS: All liver biopsies were retrieved from a series of 588 cases with histologically confirmed amyloidosis submitted between February 2006 and January 2009 to the Amyloid Registry of the Charité University Hospital. Liver biopsies had been fixed in formalin and embedded in paraffin. 3-5 microm thick paraffin sections were stained with hematoxylin and eosin and Congo red. Amyloid was classified immunohistochemically, using antibodies directed against amyloid P-component, AA amyloid, apolipoprotein AI, fibrinogen, lysozyme, lambda- and kappa-light chain, and transthyretin.
RESULTS: Amyloid was found in 46 liver biopsies (29 men, 17 women; mean age 60 years, range 34-87 years). Immunohistochemical classification succeeded in 42 cases. AL amyloidosis was present in 40 (87%) cases and was further categorized into AL amyloid of lambda-light chain origin in 26 (57%) cases, and kappa-light chain origin in 14 (30%) cases. ATTR and AA amyloidosis were found in a single patient each (2%). In 4 (9%) cases, amyloid remained unclassified.
CONCLUSIONS: Hepatic amyloidosis is most commonly AL amyloid of lambda- and kappa-light chain origin and is often associated with marked parenchymal atrophy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19415368     DOI: 10.1007/s00292-009-1133-4

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  31 in total

Review 1.  Diagnostic tools for amyloidosis.

Authors:  Eric Hachulla; Gilles Grateau
Journal:  Joint Bone Spine       Date:  2002-12       Impact factor: 4.929

2.  Immunohistochemical classification of amyloid in surgical pathology revisited.

Authors:  Anja Kebbel; Christoph Röcken
Journal:  Am J Surg Pathol       Date:  2006-06       Impact factor: 6.394

Review 3.  Amyloidosis and the heart: a comprehensive review.

Authors:  Keyur B Shah; Yoshio Inoue; Mandeep R Mehra
Journal:  Arch Intern Med       Date:  2006-09-25

4.  Diagnosis and immunohistochemical classification of systemic amyloidoses. Report of 43 cases in an unselected autopsy series.

Authors:  R J Strege; W Saeger; R P Linke
Journal:  Virchows Arch       Date:  1998-07       Impact factor: 4.064

Review 5.  Metabolic storage diseases: amyloidosis.

Authors:  Elizabeth M Brunt; Dina G Tiniakos
Journal:  Clin Liver Dis       Date:  2004-11       Impact factor: 6.126

6.  Hepatic amyloidosis: morphologic differences between systemic AL and AA types.

Authors:  F S Buck; M N Koss
Journal:  Hum Pathol       Date:  1991-09       Impact factor: 3.466

7.  The liver in systemic amyloidosis: insights from 123I serum amyloid P component scintigraphy in 484 patients.

Authors:  L B Lovat; M R Persey; S Madhoo; M B Pepys; P N Hawkins
Journal:  Gut       Date:  1998-05       Impact factor: 23.059

8.  Immunohistochemical and immunochemical study of amyloid in liver affected by systemic Alambda amyloidosis with antibodies against three different regions of immunoglobulin lambda light chain.

Authors:  Makiko Kiyama; Yoshinobu Hoshii; Dan Cui; Hiroo Kawano; Takashi Kanda; Tokuhiro Ishihara
Journal:  Pathol Int       Date:  2007-06       Impact factor: 2.534

9.  Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients.

Authors:  Miguel A Park; Paul S Mueller; Robert A Kyle; Dirk R Larson; Matthew F Plevak; Morie A Gertz
Journal:  Medicine (Baltimore)       Date:  2003-09       Impact factor: 1.889

Review 10.  Amyloidosis (AL). Clinical and laboratory features in 229 cases.

Authors:  R A Kyle; P R Greipp
Journal:  Mayo Clin Proc       Date:  1983-10       Impact factor: 7.616

View more
  3 in total

Review 1.  [Update on immunohistological classification of amyloidoses].

Authors:  C Röcken
Journal:  Pathologe       Date:  2009-12       Impact factor: 1.011

2.  Amyloid in endomyocardial biopsies.

Authors:  Barbara Kieninger; Magdalena Eriksson; Reinhard Kandolf; Philipp A Schnabel; Stefan Schönland; Arnt V Kristen; Ute Hegenbart; Peter Lohse; Christoph Röcken
Journal:  Virchows Arch       Date:  2010-04-08       Impact factor: 4.064

3.  Amyloid in biopsies of the gastrointestinal tract-a retrospective observational study on 542 patients.

Authors:  Sophie Freudenthaler; Ute Hegenbart; Stefan Schönland; Hans-Michael Behrens; Sandra Krüger; Christoph Röcken
Journal:  Virchows Arch       Date:  2016-02-25       Impact factor: 4.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.